Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Research Area
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Discover high-quality research tools to investigate GLP-1 mechanisms and next-generation metabolic targets.
OBESITY RESEARCH SOLUTIONSTrkB agonist prodrug R13 (R13) is a prodrug form of the tropomyosin-related kinase B (TrkB) activator 7,8-dihydroxyflavone (Item No. 16946).1 Oral administration of R13 (43.6 mg/kg per day) increases hippocampal phosphorylated levels of TrkB, ERK, and Akt in the 5XFAD transgenic mouse model of Alzheimer's disease. It decreases the number of malformed neurons and increases the number of neurons and active synapses in the hippocampus in 5XFAD mice. R13 decreases the number of plaques and levels of amyloid-β (1-40) (Aβ40) in the hippocampus and frontal cortex and escape latency in the Morris water maze in 5XFAD mice. It reduces the levels and activity of δ-secretase, also known as asparagine endopeptidase (Aep) and legumain, and the levels of Il-6, Tnf-α, and Il-1β in brain homogenates from 5XFAD mice.
WARNING This product is not for human or veterinary use.
1. The prodrug of 7,8-